Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis.
- DOI
- 10.1093/eurjpc/zwaf211
- Published
- 2026 Sep 4
- Container
- European journal of preventive cardiology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/eurjpc/zwaf211,
title = {Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis.},
author = {Di Giovanni G and Fujino M and Kataoka Y and Butters J and Hucko T and Puri R and Nissen SE and Nelson AJ and Psaltis PJ and Nicholls SJ},
year = {2026},
journal = {European journal of preventive cardiology},
doi = {10.1093/eurjpc/zwaf211},
url = {https://doi.org/10.1093/eurjpc/zwaf211}
}RIS
TY - JOUR TI - Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis. AU - Di Giovanni G AU - Fujino M AU - Kataoka Y AU - Butters J AU - Hucko T AU - Puri R AU - Nissen SE AU - Nelson AJ AU - Psaltis PJ AU - Nicholls SJ PY - 2026 JO - European journal of preventive cardiology DO - 10.1093/eurjpc/zwaf211 UR - https://doi.org/10.1093/eurjpc/zwaf211 ER -
APA
G, D. G., M, F., Y, K., J, B., T, H., R, P., SE, N., AJ, N., PJ, P., & SJ, N. (2026). Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis.. European journal of preventive cardiology. https://doi.org/10.1093/eurjpc/zwaf211
Source records
- pubmed · retrieved 2026-09-26T07:19:49.664Z